معرفی
Professor Simon Laws is a leading academic in Translational Genomics at Edith Cowan University’s School of Medical and Health Sciences. He serves as the inaugural Director of the Centre for Precision Health, a strategic research center, and leads the Collaborative Genomics and Translation Group. His work bridges genomics, epigenetics, and lifestyle factors to improve health outcomes through personalized interventions.
- Professor of Translational Genomics, Edith Cowan University (2020–present)
- Director, Centre for Precision Health (2021–present)
- Associate Professor, Edith Cowan University (2011–2020)
- Deputy Chief Scientific Officer, CRC for Mental Health (2011–2017)
Simon Laws’ research focuses on the genomic architecture of Alzheimer’s disease and cognitive decline, examining genetic and epigenetic risk profiles, methylation patterns, and the interaction of genomics with lifestyle. His work extends to human performance, aiming to optimize training and prevent injury through genetic insights. His research employs advanced biological technologies and analytical methods to develop precision health strategies.
The most recent publications (2024–2025) highlight a strong focus on plasma biomarkers (e.g., p-tau217), polygenic risk scores, DNA methylation, and the interplay between vascular health, genetics, and neurodegeneration. His work frequently involves large-scale collaborations and cohort studies such as the AIBL study, with publications appearing in high-impact journals like Nature Communications, Alzheimer's & Dementia, and EBioMedicine.
- Vice-Chancellor's Award for Excellence in Research (2019)
Professor Laws is actively involved in advising and collaborative research across Australia and internationally. He has participated in numerous studies examining the role of exercise, sleep, diet, and genetic variants in brain health and cognitive aging. He is affiliated with key professional societies including the Australasian Neuroscience Society and the Alzheimer’s Association’s ISTAART. His research is supported by institutional and collaborative funding, enabling large-scale genomic and translational studies.
He leads the Collaborative Genomics and Translation Group within the Centre for Precision Health, fostering interdisciplinary research and innovation in precision medicine. The team focuses on integrating multi-omics data with clinical and lifestyle factors to develop early detection and intervention strategies for neurodegenerative diseases.
